Cargando…
Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004159/ https://www.ncbi.nlm.nih.gov/pubmed/35410264 http://dx.doi.org/10.1186/s13046-022-02324-2 |
| _version_ | 1784686230662807552 |
|---|---|
| author | Roca, Maria Serena Moccia, Tania Iannelli, Federica Testa, Cristina Vitagliano, Carlo Minopoli, Michele Camerlingo, Rosa De Riso, Giulia De Cecio, Rossella Bruzzese, Francesca Conte, Mariarosaria Altucci, Lucia Di Gennaro, Elena Avallone, Antonio Leone, Alessandra Budillon, Alfredo |
| author_facet | Roca, Maria Serena Moccia, Tania Iannelli, Federica Testa, Cristina Vitagliano, Carlo Minopoli, Michele Camerlingo, Rosa De Riso, Giulia De Cecio, Rossella Bruzzese, Francesca Conte, Mariarosaria Altucci, Lucia Di Gennaro, Elena Avallone, Antonio Leone, Alessandra Budillon, Alfredo |
| author_sort | Roca, Maria Serena |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9004159 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90041592022-04-13 Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation Roca, Maria Serena Moccia, Tania Iannelli, Federica Testa, Cristina Vitagliano, Carlo Minopoli, Michele Camerlingo, Rosa De Riso, Giulia De Cecio, Rossella Bruzzese, Francesca Conte, Mariarosaria Altucci, Lucia Di Gennaro, Elena Avallone, Antonio Leone, Alessandra Budillon, Alfredo J Exp Clin Cancer Res Correction BioMed Central 2022-04-11 /pmc/articles/PMC9004159/ /pubmed/35410264 http://dx.doi.org/10.1186/s13046-022-02324-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Roca, Maria Serena Moccia, Tania Iannelli, Federica Testa, Cristina Vitagliano, Carlo Minopoli, Michele Camerlingo, Rosa De Riso, Giulia De Cecio, Rossella Bruzzese, Francesca Conte, Mariarosaria Altucci, Lucia Di Gennaro, Elena Avallone, Antonio Leone, Alessandra Budillon, Alfredo Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation |
| title | Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation |
| title_full | Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation |
| title_fullStr | Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation |
| title_full_unstemmed | Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation |
| title_short | Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation |
| title_sort | correction to: hdac class i inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via foxm1 modulation |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9004159/ https://www.ncbi.nlm.nih.gov/pubmed/35410264 http://dx.doi.org/10.1186/s13046-022-02324-2 |
| work_keys_str_mv | AT rocamariaserena correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT mocciatania correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT iannellifederica correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT testacristina correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT vitaglianocarlo correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT minopolimichele correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT camerlingorosa correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT derisogiulia correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT dececiorossella correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT bruzzesefrancesca correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT contemariarosaria correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT altuccilucia correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT digennaroelena correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT avalloneantonio correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT leonealessandra correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation AT budillonalfredo correctiontohdacclassiinhibitordomatinostatsensitizespancreaticcancertochemotherapybytargetingcancerstemcellcompartmentviafoxm1modulation |